Correlation Between Neuropace and Profound Medical

Can any of the company-specific risk be diversified away by investing in both Neuropace and Profound Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Profound Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Profound Medical Corp, you can compare the effects of market volatilities on Neuropace and Profound Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Profound Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Profound Medical.

Diversification Opportunities for Neuropace and Profound Medical

-0.31

Correlation Coefficient

Neuropace  Profound Medical

Very good diversification

The 3 months correlation between Neuropace and Profound is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Profound Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Profound Medical Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Profound Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Profound Medical Corp has no effect on the direction of Neuropace i.e., Neuropace and Profound Medical go up and down completely randomly.

Pair Corralation between Neuropace and Profound Medical

Given the investment horizon of 90 days Neuropace is expected to under-perform the Profound Medical. In addition to that, Neuropace is 1.0 times more volatile than Profound Medical Corp. It trades about -0.22 of its total potential returns per unit of risk. Profound Medical Corp is currently generating about -0.03 per unit of volatility. If you would invest  499.00  in Profound Medical Corp on May 18, 2025 and sell it today you would lose (74.00) from holding Profound Medical Corp or give up 14.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Profound Medical Corp

Neuropace

Risk-Adjusted Performance

Weakest

Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in September 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Profound Medical Corp

Risk-Adjusted Performance

Weakest

Over the last 90 days Profound Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Neuropace and Profound Medical

The main advantage of trading using opposite Neuropace and Profound Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Profound Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will offset losses from the drop in Profound Medical's long position.

The idea behind Neuropace and Profound Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.